Changeflow GovPing Pharma & Drug Safety Patent Application for Plant Regulatory Element...
Routine Notice Added Draft

Patent Application for Plant Regulatory Elements and Uses

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO has published a patent application (US20260085324A1) detailing novel synthetic small nuclear RNA (snRNA) promoters for CRISPR-mediated gene modifications in plants. The application, filed on October 3, 2025, includes methods and compositions for developing plants with modified genomes using these promoters.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a published patent application from the USPTO, specifically application US20260085324A1, filed on October 3, 2025. It describes novel synthetic small nuclear RNA (snRNA) promoters designed for CRISPR-mediated targeted gene modifications in plants. The application also covers methods and compositions utilizing these promoters to drive the expression of guide RNAs and non-coding RNAs, aiming to develop plants and plant cells with modified genomes.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signifies potential future developments in plant biotechnology and gene editing. Companies operating in the agricultural and pharmaceutical sectors, particularly those involved in genetic modification or CRISPR technology, should monitor this and related patent filings for potential intellectual property implications and future technological advancements.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PLANT REGULATORY ELEMENTS AND USES THEREOF

Application US20260085324A1 Kind: A1 Mar 26, 2026

Inventors

Ian W. Davis, Matthew S. Marengo, Ervin D. Nagy

Abstract

The invention provides novel synthetic small nuclear RNA (snRNA) promoters which are useful for CRISPR-mediated targeted gene modifications in plants. The invention also provides methods and compositions for use for the snRNA promoters driving expression of guide RNAs and non-coding RNAs for development of plants and plant cells comprising modified genomes.

CPC Classifications

C12N 15/8213

Filing Date

2025-10-03

Application No.

19349509

View original document →

Named provisions

Inventors Abstract CPC Classifications

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
October 3rd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085324A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Gene Editing Plant Biotechnology
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!